US 10646550
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted A61KA61K38/1709A61K38/2242
Quick answer
US patent 10646550 (Use of C-type natriuretic peptide variants to treat skeletal dysplasia) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/1709, A61K38/2242, A61K47/10, A61K47/12